Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/44024
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
- IOC - Artigos de Periódicos [12659]
Metadatos
Mostrar el registro completo del ítem
ATYPICAL MUCOCUTANEOUS LEISHMANIASIS CAUSED BY LEISHMANIA BRAZILIENSIS IN AN ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENT: T-CELL RESPONSES AND REMISSION OF LESIONS ASSOCIATED WITH ANTIGEN IMMUNOTHERAPY
Síndrome da Imunodeficiência Adquirida
Células CD8 +
Interferon-γ
Imunoterapia
Acquired immunodeficiency syndrome
CD8+ cells
Interferon-γ
Immunotherapy
Autor
Afiliación
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Protozoologia. Laboratório de Imunidade Celular e Humoral. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Serviço de Dermatologia. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Serviço de Dermatologia. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Departamento de Parasitologia. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Pesquisa em Leishmanioses. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Serviço de Dermatologia. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Estado do Rio de Janeiro. Hospital Universitário Gaffrée-Guinle. Serviço de Dermatologia. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Departamento de Parasitologia. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Imunologia. Laboratório de Pesquisa em Leishmanioses. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.
Resumen en ingles
An atypical case of acquired immunodeficiency syndrome-associated mucocutaneous lesions due to
Leishmania braziliensis is described. Many vacuolated macrophages laden with amastigote forms of the
parasite were found in the lesions. Leishmanin skin test and serology for leishmaniasis were both negative. The patient was resistant to therapy with conventional drugs (antimonial and amphotericin B).
Interestingly, remission of lesions was achieved after an alternative combined therapy of antimonial
associated with immunotherapy (whole promastigote antigens). Peripheral blood mononuclear cells
were separated and stimulated in vitro with Leishmania antigens to test the lymphoproliferative responses (LPR). Before the combined immunochemotherapy, the LPR to leishmanial antigens was negligible (stimulation index - SI=1.4). After the first course of combined therapy it became positive (SI=4.17).
The antigen responding cells were predominantly T-cells (47.5%) most of them with CD8+ phenotype
(33%). Very low CD4+ cells (2.2%) percentages were detected. The increased T-cell responsiveness to
leishmanial antigens after combined therapy was accompanied by interferon-γ (IFN-γ) production as
observed in the cell culture supernatants. In this patient, healing of the leishmaniasis lesions was associated with the induction of a specific T-cell immune response, characterized by the production of
IFN-γ and the predominance of the CD8+ phenotype among the Leishmania-reactive T-cells.
Palabras clave en portugues
Leishmaniose mucocutânea humanaSíndrome da Imunodeficiência Adquirida
Células CD8 +
Interferon-γ
Imunoterapia
Palabras clave en ingles
Human mucocutaneous leishmaniasisAcquired immunodeficiency syndrome
CD8+ cells
Interferon-γ
Immunotherapy
Compartir